Fractional commercial leadership · Omics & life sciences

Senior leadership.
Without the full-time cost.

Early-stage life sciences companies deserve CCO-level commercial thinking from day one. LifeSci Principals gives you that embedded, strategic, and built for the pace of biotech.

AI gives a fractional leader the output of a full team. You still need the leader.

20+
Years in life sciences
Seed–A
Stage focus
US + EU
Market reach

You don't need a full-time hire.
You need the right mind in the room.

A Chief Commercial Officer costs $300–500K all-in before you've closed your first enterprise deal. Fractional engagement gives you that same strategic horsepower at the moment you actually need it, for a fraction of the investment.

What you get

A senior commercial principal embedded in your team attending your leadership meetings, advising your founders, and owning your go-to-market strategy. Not a consultant who disappears between engagements. Someone who shows up.

What you avoid

A premature full-time hire who burns runway before product-market fit is confirmed. The eighteen-month learning curve of a first commercial leader who's never navigated the omics buyer. A board conversation about why commercial costs are outpacing pipeline.

The full scope of
commercial leadership.

Most early-stage teams underestimate how much a CCO actually owns. Here's the work named explicitly, so you know exactly what you're getting.

01
Product-market fit validation
Translating scientific differentiation into buyer language. Pressure-testing ICP assumptions against real market signal before committing budget to the wrong segment.
02
Go-to-market architecture
Channel strategy, pricing model, partnership vs. direct sales decision, and sequencing of market entry built for the realities of omics and precision measurement commercialization.
03
BD hiring and buildout
Writing the job specs, running the interview process, onboarding your first commercial reps, and building comp plans that attract the right talent without overcommitting equity.
04
US market penetration
For European companies entering the US market: key account prioritization, KOL strategy, regulatory pathway navigation, and building the local commercial infrastructure from scratch.
05
Board and investor communication
Translating commercial momentum into the metrics investors understand pipeline, bookings, NRR, win rates and building the reporting cadence that keeps confidence high between rounds.
06
Commercial operations foundation
CRM selection and implementation, pipeline hygiene, deal stage design, and reporting infrastructure the scaffolding your first full-time hire will thank you for building correctly.

The judgment is human.
AI removes the drag.

In the age of AI, a fractional leader can now deliver the output of a full commercial team. Market analysis that took two weeks takes two days. Pipeline diagnostics that required a dedicated analyst are now continuous. The leverage is real but only when there's a senior operator directing it.

AI won't read a room, build a relationship, or make a judgment call under pressure. You still need a human in the mix. That's what we are.

ICP validation at speed
AI stress-tests audience assumptions against real market signal in hours, not weeks before you commit budget to the wrong segment.
Deal stage diagnostics
Continuous pipeline analysis reveals where deals stall, which patterns predict wins, and where the commercial process is leaking without waiting for a quarterly review.
Content and collateral at scale
Pitch decks, battlecards, case studies, and sales playbooks produced in days. A one-person function with the output of a three-person team.
Competitive intelligence, continuously
Automated monitoring of competitor positioning, pricing moves, and hiring patterns keeping strategy current without a dedicated analyst on payroll.
BD onboarding acceleration
AI-assisted territory planning, account prioritization, and playbook creation cuts new rep ramp time significantly so your first hire becomes productive faster.

The Commercial Audit.

Not sure where your commercial gaps are? The Commercial Audit is a fixed-scope diagnostic that gives you clarity in 30 days with a written report and readout session, so you leave with a clear plan, not just observations.

01
ICP validation
Who is actually buying versus who you think is buying and why the gap between those two answers matters for your next twelve months.
02
Competitive positioning
Where you win, where you lose, and the honest reasons for both grounded in real buyer language, not internal assumptions.
03
Go-to-market readiness
Channel, pricing, and sequencing assessment including an honest view of whether you're ready to sell, or whether something needs to be resolved first.
04
Commercial infrastructure review
CRM, pipeline hygiene, reporting gaps, and the foundational tooling decisions that will compound over time if you get them right now.
05
Hiring gap analysis
What commercial roles you need, in what order, and what to look for so your first BD hire is additive, not a costly course correction.
06
US market entry assessment
For European companies: key account prioritization, reimbursement landscape overview, and the specific sequencing decisions that determine whether US launch succeeds or stalls.

Audit at a glance

Duration 30 days
Format Written report + readout
Scope Fixed
Deliverable 90-min strategy session
Next step Optional retainer

The audit is the natural entry point to an ongoing engagement but there is no obligation. Many clients use it as a standalone diagnostic.

Built around your stage.
Aligned with your outcomes.

All engagements are monthly retainers with flexible exit terms. We also offer an equity option for seed-stage companies who want to align incentives from the start. Reach out to discuss specific pricing for your situation.

Advisory
One day per week · Minimum 3 months

The right level of engagement for companies that need a senior commercial voice in the room regularly but are not yet ready for full embedded support.

  • Weekly strategy session
  • Commercial roadmap development
  • Async advisory between sessions
  • Board prep and investor materials
  • Equity option available
Inquire about pricing
Custom
Scoped to your specific needs

For situations that fall outside the standard tiers: US market entry programs, multi-functional coverage, Commercial Audit as a standalone entry point, or equity-first structures.

  • US market entry programs
  • Commercial Audit as a starting point
  • Multi-functional leadership coverage
  • Network specialist access
  • Equity-first structures available
Discuss your situation
Equity option
For seed-stage companies that are cash-constrained but asset-rich, we offer a reduced monthly retainer in exchange for a small equity position. We align our incentives with your outcomes. This is not a discount; it is a partnership structure. Ask us about it when you reach out.

Built for a specific
kind of company.

We work best with early-stage companies in omics, proteomics, mass spectrometry, spatial biology, and adjacent precision measurement where the science is exceptional but commercial momentum needs a dedicated senior hand.

Seed and Series A companies
Pre-commercial or early commercial stage before a full-time CCO hire makes economic sense, but past the point where commercial strategy can wait.
European companies entering the US
Proteomics, mass spec, and multi-omics companies with strong European foundations who need a senior US commercial presence without opening a full office.
Companies hiring their first BD
Founders who need a senior operator to build the job spec, run the process, and onboard the hire correctly so the first commercial role doesn't become an expensive lesson.
Investor-backed omics platforms
Companies with strong scientific IP and investor pressure to demonstrate commercial traction where the gap between the science and the pipeline needs closing quickly.
"We built the commercial team, found a local facility to house the lab, improved bookings flow, and established the foundation that let the business scale. That's the work."
What this looks like in practice The full scope of embedded commercial leadership from HR systems and team construction to pipeline architecture and bookings cadence built in parallel with a company finding its commercial footing in the US market. This is the engagement model we believe in.

Ready to talk about
your commercial trajectory?

The first conversation is always complimentary. Tell us where you are, where you're trying to get to, and we'll tell you honestly whether we're the right fit.

info@lifesciprincipals.bio We respond within one business day